Recent Updates
Recently added Catalysts
SNTI Positive Sentiment

Rob Cutler, J.D.

Wednesday, December 13, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Rob Cutler has been appointed as the Senior Vice President and Head of Legal Affairs at Synthetech, effective November 2024. He brings a wealth of experience from his previous roles, including Chief Legal Officer at Telesis Bio and General Counsel at Synthetic Genomics. His background in biotech law and business development positions him well for this role.
Price reaction · baseline $3.501 (2023-12-12 close) · hit pre-market · clean, no other SNTI news in the window
day 0 close
+7.1%
day 1
+8.5%
day 3 · peak
+17.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Rob Cutler has extensive experience in legal affairs within the biotech industry.
  • His previous roles at notable companies enhance his qualifications.
  • He has a strong educational background with a Juris Doctorate.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+84%
120-day peak, hindsight
Typical move
76.7%
average across 4 past catalysts
Cash runway
~5 mo
High dilution risk
Lead asset
SENTI-202
Phase 1 · AML/MDS

Full Press Release Details

Mr. Cutler has served as our SVP – Head of Legal Affairs since November 2024. From 2021 to November 2024, Mr. Cutler served as Chief Legal Officer for Telesis Bio Inc. From 2016 to 2021, Mr. Cutler served as General Counsel for Synthetic Genomics, Inc. (now Viridos, Inc.). From 2012-2015, Mr. Cutler was General Counsel for LifeVantage Corporation, a public dietary supplement company. Prior to LifeVantage, Mr. Cutler served as Vice President, Business Development for Somaxon Pharmaceuticals after spending 9 years at Biogen Idec (now Biogen) in a variety of legal and business development roles. Mr. Cutler began his career in two large law firms focusing his practice on private and public biotech clients. Mr. Cutler earned a Juris Doctorate from Brigham Young University and a Bachelor of Arts in Finance from the University of Utah.

Frequently Asked Questions

What position has Rob Cutler been appointed to?

Rob Cutler has been appointed as the Senior Vice President and Head of Legal Affairs at Synthetech.

What experience does Rob Cutler bring to Synthetech?

He has extensive experience in legal affairs from previous roles at Telesis Bio and Synthetic Genomics.

When did Rob Cutler's appointment take effect?

His appointment took effect in November 2024.

Where did Rob Cutler earn his Juris Doctorate?

He earned his Juris Doctorate from Brigham Young University.

ShareAdd on Google
Tags: SNTI Viatris Investor Conferences Healthcare Synthetech Rob Cutler legal affairs biotech Telesis Bio
Last updated: Dec 13, 2023

Biotech snapshot

Cash runway
$19M liquidity · $2M/mo burn
~5 mo
High dilution risk
Lead asset
SENTI-202Phase 1
AML/MDS →

Catalyst track record

+84%
best trade around SNTI's most recent catalyst

Peak hindsight return over a 120-day window, across 4 tracked FDA/PDUFA catalysts for SNTI.

See every catalyst's timing & PoA →